GLOBAL RESEARCH ARCHIVE
Truist Securities Daily Spotlight
Research evidence excerpt
Truist Securities Daily Spotlight
ATES increased visibility into the stability of relationships with frontier
labs mitigates risk around what we see as the most likely NT
Gaming - Gaming - Busy Days and Golden Knights: Takeaways risk to the bull thesis. As such, we see opportunity for continuedfrom Las Vegas Management Meetings
upside momentum in shares, raise PT to $300. - Miller Jump
Application Software and Agentic AI - Tillman's Software Monday
Morning Missives PACS Group, Inc. (PACS, $36.28, Buy) - PACS - Takeaways
From Management Meetings, Reiterate Buy - We remain bullishApplication Software and Agentic AI - Software & Agentic AI: Code
Talkers Series – GCP & Coding Agent Subject Matter Expert on PACS post upbeat management meetings highlighting
the company's strong positioning, attractive demand trends,
Energy - Energy - Weekly Refrac: Peace Framework; OPEC/EIA clinical/operational execution and ongoing regulatory-focused
Outlooks; US SPR; APA; DVN Pro-Forma Guide; FERC Call; investment activity. We expect continued expansion to nicelyKNICKS!
complement core growth with management noting a solid pipeline
Biotechnology - Biotech - EHA 2026 Wrap - AGIO, ONC, NRIX, of opportunities, and we continue to see attractive embedded
GMAB, GILD, AAPG earnings within new/ramping facilities. Financial flexibility remains
Banks - LOANS: 3D - Double Digit Deposits a key strength with strong liquidity, minimal leverage and brisk
CF which we expect to support ongoing investment/execution/
Pharmaceuticals - INCY, LLY - EHA26 updates on MF potential for M&A. We reiterate our Buy, $52 PT and like the absolute/relativeboth disease modifying mCALR and symptomatic control
valuation risk/reward. - David MacDonald
Biotechnology - Biotech - EHA 2026 Day 2 Takeaways - Focus on
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer